Form 4 for ISRG Intuitive Surgical
Accepted 2023-04-24 00:00:00 ET · period of report 2023-04-21 · accession 0001035267-23-000107 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-04-24 | 2023-04-21+ | ISRG | Rosa David J. | EVP Chief Strategy, Growth Of | S - Sale+OE | $298.56 | -81.6K | 155.7K | -34% | -$24.35M |
| DM | 2023-04-24 | 2023-04-21+ | ISRG | Rosa David J. | EVP Chief Strategy, Growth Of | M - OptEx | $42.64 | +108.0K | 183.3K | +143% | +$4.61M |
| DM | 2023-04-24 | 2023-04-21+ | ISRG | Rosa David J. | EVP Chief Strategy, Growth Of | M - OptEx | $0.00 | -108.0K | 54.0K | -67% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-21 | S | D | 40,800 | $297.92 | 142,476 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.54 to $299.47 as follows: 9,698 shares sold at $296.54 to $297.54; 25,403 shares sold at $297.55 to $298.53; and 5,699 shares sold at $298.60 to $299.47. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2023-04-24 | S | D | 40,764 | $299.20 | 155,712 | D | — | — | (F3) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $297.79 to $301.83 as follows: 10,560 shares sold at $297.79 to $298.78; 28,240 shares sold at $298.84 to $299.84; 1,364 shares sold at $299.99 to $300.50; and 600 shares sold at $301.83. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2023-04-24 | M | A | 54,000 | $42.64 | 196,476 | D | — | — | |
| 4 | Common | Common Stock | 2023-04-21 | M | A | 54,000 | $42.64 | 183,276 | D | — | — | |
| 5 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-04-24 | M | D | 54,000 | $0.00 | 0 | D | $42.64 · — to 2023-08-15 | 54,000 Common Stock | (F4) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. |
| 6 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-04-21 | M | D | 54,000 | $0.00 | 54,000 | D | $42.64 · — to 2023-08-15 | 54,000 Common Stock | (F4) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. |